Communiqués Mayne Pharma Group Limited

Actions

MYX

AU000000MYX0

Marché Fermé - Australian S.E. Autres places de cotation 08:10:50 11/06/2024			Varia. 5j.	Varia. 1 janv.
4,66 ^AUD	-1,27 %		-4,90 %	-24,23 %

24/05	Mayne Pharma réitère ses perspectives pour le second semestre de l'exercice 24 après la cyberattaque de Change Healthcare	MT
24/05	Le plan de rachat d'actions de Mayne Pharma Group Limited prolongé jusqu'au 29 novembre 2024.	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Mithra announces grant of two additional U.S. patents for NEXTSTELLIS	13/05	AQ
MAYNE PHARMA REPORTS 1H FY24 RESULTS WITH A 43% INCREASE IN REVENUE TO A$188 MILLION AND $8 MILLION UNDERLYING EBITDA	27/02	AQ
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference	29/12	AQ
MAYNE PHARMA PROVIDES UPDATE ON FIRST QUARTER 2024 TRADING AND OUTLOOK	19/10/23	AQ
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition	10/04/23	AQ
Mayne Pharma and Mithra announce US launch of HALOETTE, a generic version of NUVARING	16/01/23	AQ
MAYNE PHARMA COMPLETES SALE OF METRICS CONTRACT SERVICES	05/10/22	AQ
MAYNE PHARMA - APPOINTMENT OF CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR	29/09/22	AQ
MAYNE PHARMA GROUP - NON-EXECUTIVE DIRECTOR APPOINTMENT AND RETIREMENT	31/08/22	AQ
Mayne Pharma : CEO announces plan to retire	19/08/22	PU
Mayne Pharma : announces sale of Metrics Contract Services	10/08/22	PU
Mayne Pharma : and Mithra announce FDA approval of Haloette, a generic version of Nuvaring	08/08/22	PU
MAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS AND EXPAND ACCESS TO BIRTH CONTROL	01/08/22	AQ
Mayne Pharma Group Limited and Mithra Pharmaceuticals - NEXTSTELLIS ORAL CONTRACEPTIVE NOW AVAILABLE IN AUSTRALIA	27/07/22	AQ
Mayne Pharma : New Chief Financial Officer appointment	22/07/22	PU
Mayne Pharma : Wilsons investor conference presentation	26/05/22	PU
MAYNE PHARMA ANNOUNCED AS RECIPIENT OF $4.8M FEDERAL GOVERNMENT GRANT	09/05/22	AQ
Mayne Pharma Group Limited - NON-EXECUTIVE DIRECTOR APPOINTMENT	22/03/22	AQ
Mayne Pharma : 22/03/2022 Non Executive Director Appointment	21/03/22	PU
MAYNE PHARMA REPORTS 1HFY22 RESULTS	28/02/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Mayne Pharma Group Limited

Actions

MYX

AU000000MYX0

Communiqués

Filtres